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Abstract
Zellweger fibroblasts, which are devoid of peroxisomes and fail to synthesize plasmalogens, are very sensitive to the
 .  .killing effect triggered by UV-activated 12- 1-pyrene dodecanoic acid P12 . Although in some studies performed, it is
 .assumed that reactive oxygen species ROS may damage plasma membrane causing necrosis, other studies suggest that
ROS are involved in apoptotic cell death induced by a wide variety of stimuli. Analysing the P12 dose-response in
 .Zellweger fibroblasts, we observed that at high doses 1–2 mM , more than 75% of the cells died after 24 h. This behaviour
suggested that, at high doses, P12 kills the cells by unspecific lytic mechanisms or by necrosis, while at low doses 0.1–0.5
.mM , an apoptotic mechanism could be involved. Cytofluorimetric analysis of Zellweger fibroblasts-treated with activated
 .P12 0.5 mM did not show morphological modifications typical of apoptotic cell death. This was supported by comparative
 .  .staining of fibroblast nuclei, DNA gel electrophoresis and identification of poly ADP-ribose polymerase PARP cleavage
and Bcl-2 expression, assayed by Western blots. Thus, our results, while confirming the importance of plasmalogens in the
protection against ROS, establish that apoptosis is not involved in photodynamic death induced by activated P12. Therefore,
we can expect that in gene transfer experiments, the rescue of Zellweger cells will be dependent only on the correction of
peroxisomal biogenesis. q 1998 Elsevier Science B.V.
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1. Introduction
 .Compounds such as 12- 1-pyrene dodecanoic acid
 .P12 can be defined as effectors in supramolecular
photochemistry. According to Balzani and Scandola
w x1 , these kind of molecules, while conserving the
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typical properties of individual components, gain new
properties intrinsic to the new configuration. Thus,
for example, the dodecanoic moiety of P12 can be
readily esterified into phospholipids giving rise to
compounds carrying a fluorescent tag represented by
a pyrene molecule. This approach has generally been
applied to studies regarding flip–flop of membrane
phospholipids or their lateral movements in mem-
w xbranes 1 . However, an equally interesting use of
P12 is to study energy transfer or electron transfer to
other molecules situated in its proximity once photo
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excitation at the proper wavelength has been trig-
w xgered 1 .
Comparing normal to Zellweger fibroblasts we
have confirmed the extreme sensitivity of cells lack-
ing peroxisomes to the killing effect of reactive oxy-
 .gen species ROS . This was largely due to the
deficient synthesis of plasmalogens, since addition of
 .PAF 10–40 mM strongly counteracted the lytic
effect of ROS generation. DHAP acyltransferase ac-
tivity was restored following peroxisome assembly
w xfactor transfection in CHO cells 2,3 . Since this
involved the restoration of resistance to P12rUV
selection procedure, it means that plasmalogen
biosynthesis was normalised. Thus, the strong reduc-
tion of DHAP acyltransferase in Zellweger fibrob-
 .lasts less than 10% of control is not due to gene
expression modifications but to an instability of the
w xenzyme when mislocated 4 .
w xHoefler et al. 5 have pointed out the possibility of
using a P12 selection procedure to identify new genes
involved in peroxisome biogenesis, taking advantage
of the success in the characterization of the genetic
w xdefect in Xeroderma pigmentosum 6 . Since the
techniques used involve the isolation of transfected
cells from the bulk of nontransfected ones, it is
important to ascertain whether the rescue mechanism
involves any modification of the apoptotic program.
2. Materials and methods
2.1. Materials
 X .  . X X12- 1-Pyrene dodecanoic acid P12 ; 2 ,7 -dichlo-
 .rofluorescin diacetate DCFHDA and dihydroethid-
 .ium DHE were purchased from Molecular Probes
 .Junction City, OR . PAF C-16 was purchased from
 .Cascade Biochem Berkshire, England . Minimum
 .Essential Medium MEM , glutamine, penicil-
 .linrstreptomycin, dimethylsulfoxide DMSO , bovine
 .serum albumin BSA , trypsin–EDTA, trypan blue,
 .  .propidium iodide PI , Hoechst 33342 HO 33342 ,
agarose, lambda phage DNA marker, proteinase K,
RNase A, Igepal CA-630 were purchased from Sigma
 .  .St. Louis, USA . Foetal Calf Serum FCS was
purchased from Biological Industries Kibbutz, Is-
.  .  .rael . Bcl-2 monoclonal , poly ADP-ribose poly-
 .  .merase PARP goat polyclonal and horseradish
 .peroxidase HRP -conjugated secondary antibodies
were purchased from Santa Cruz Biotechnology
 .Santa Cruz, USA .
2.2. Cell and culture conditions
Fibroblasts were obtained from the American Type
Culture Collection. Strain AG01437B normal fore-
. skin fibroblasts and GM00228A fibroblasts from
.patients affected by Zellweger syndrome were grown
at 378C in a 5% CO air atmosphere in MEM2
 .  .supplemented with FCS 20% , glutamine 1 mM ,
 . penicillin 100 unitsrml and streptomycin 0.1
.mgrml . P12 was added to the growth medium, by a
 .dilution of a concentrated stock solution 20 mM
prepared in DMSO.
2.3. Peroxisome staining
Catalase was detected as described by Masuda et
w xal. 7 .
2.4. P12 localisation
Zellweger fibroblasts were grown on coverslips
and incubated with 10 mM P12 for 20 h. After three
 .washes with phosphate-buffered saline PBS con-
taining 1% BSA and three washes with PBS, the
coverslips were mounted in glycerol–PBS medium.
Samples were visualised using a Leitz fluorescence
microscope.
2.5. P12rUV killing
For the UV killing experiments, cells were incu-
bated for 20 h with P12 at different concentrations
 .0.1–4 mM . After this incubation, the medium con-
taining P12 was removed, cells were washed twice
and then irradiated for 4 min with an UV transillumi-
 .nator UV gen, BioRad, Hercules, USA , excluding
the wavelengths below 300 nm by using a glass plate,
1 mm thick, positioned between the tissue culture
dishes and the UV source, as described by Zoeller et
w xal. 8 . After 3–24 h from irradiation, surviving cells
were detached by using a trypsin–EDTA solution and
collected to perform the experiments.
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2.6. Cell ˝iability
Cell viability was determined by using the trypan
blue exclusion test. Cells, detached by using
trypsin–EDTA, were stained with a trypan blue solu-
tion and counted in a Burker slide.
2.7. Integrity of the plasma membrane
Plasma membrane integrity, which is lost in
necrotic but not in apoptotic cells, was probed by the
exclusion of PI. Zellweger cells after 12 h from the
 .treatment activated P12, 0.5 mM were stained with
 .PI 5 mgrml and observed by a Leitz fluorescence
microscope.
2.8. Nuclear morphology
 .Hoechst 33342 HO 342 was used to observe the
nuclear morphology of Zellweger cells after 12 h
 .Fig. 1. DAB staining of peroxisomes in normal A and Zell-
 .  .weger B cultured fibroblasts 1000= . nsnucleus, ps
peroxisomes.
 .Fig. 2. Photosensitized killing of cultured normal N and Zell-
 .weger Z fibroblasts due to UV-activated P12. Zellweger fibrob-
last started to die 3 h after the treatment. The data reported here
were collected 20 h after the treatment. Values are mean"SEM
 .of two separate experiments ns8 . Differences between normal
 .and Zellweger cell survival are significant P -0.05 for the
range 0.1–2 mM P12.
 .from the treatment activated P12, 0.5 mM . Cells
were fixed in 4% paraformaldehyde for 30 min at
48C, rinsed with PBS, stained with HO 342 1 mgrml,
.15 min and observed under UV illumination.
2.9. Flow cytometry
Flow cytometry analysis were performed with a
BioRad Bryte instrument. In order to measure the
intracellular peroxides content, cells were incubated
X X with 2 ,7 -dichlorofluorescin diacetate DCHFDA, 2
.mM for 15 min at 378C. Likewise, intracellular
superoxide anions were measured following the red
fluorescence emission derived from the oxidation of
. w xDHE, 10 mgrml 9 . Forward angle light scatter and
right scatter were used to select living and dead cells
w x10 . Viability was confirmed by fluorescein diacetate
 . w xFDA positive and PI negative staining 11 . Fluores-
cence was collected through a 488 nm blocking filter,
 .  .a 525"10 nm DCF and a 630"15 nm HE band
pass filters.
2.10. Gel electrophoresis
Untreated Zellweger fibroblasts and Zellweger fi-
broblasts treated with 0.1 or 0.5 mM P12 were
detached and collected by centrifugation 3, 6 or 12 h
after UV irradiation and the electrophoresis was per-
w xformed essentially as described by Gong et al. 12 .
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 .Fig. 3. Localization of P12 by fluorescence in Zellweger fibroblasts 1000= . P12 was incubated as described under Section 2.
 .Fig. 4. Time-dependent superoxide production A , expressed as
 .red fluorescence, and H O production B , expressed as green2 2
 .  .fluorescence, in normal N and Zellweger fibroblasts Z after
treatment with 0.5 mM activated P12. The fluorescence intensity
was read directly from the flow cytometer, set as described under
Section 2. Results are the mean"SEM of three independent
experiments. No significative differences between normal and
 .Zellweger cells are evident P )0.1 .
Briefly, cells were fixed in suspension with ice-cold
70% ethanol, stored at y208C for 24 h and then
centrifuged at 200=g for 5 min to remove the
 6 .ethanol. Cell pellets 3=10 cells were resuspended
 .in 80 ml of phosphate–citrate PC buffer, consisting
of 192 parts of 0.2 M Na HPO and 8 parts of 0.1 M2 4
 .citric acid pH 7.8 at room temperature for at least
30 min. After centrifugation at 1000=g for 5 min,
the supernatant was transferred to new tubes and
Fig. 5. Protective effect of PAF on P12 mediated photosensitized
 .killing in Zellweger fibroblasts Z . PAF was added to the cell
 .medium in addition to P12. PAF had no effect on normal N
 .fibroblasts viability. Values are means"SEM ns6 . The pro-
 .tective effect is significant P -0.05 for the range 1–2 mM
P12.
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concentrated by vacuum in a Hetovac concentrator
 .Heto, Scandinavia for 20 min. A 3-ml aliquot of
0.25% Igepal CA-630 in distilled water was added
followed by 3 ml of a solution of RNase A 1 mgrml
.in water . After a 30-min incubation at 378C, 3 ml of
 .a solution of proteinase K 1 mgrml was added, the
extract was incubated for an additional 30 min at
378C and transferred to the gel with 12 ml of loading
buffer 0.25% bromophenol blue, 0.25% xylene
.cyanol FF, 30% glycerol . Horizontal 0.8% agarose
Fig. 6. Fluorescence microscopy of PI stained Zellweger cells. Cells treated with 0.5 mM activated P12 were stained with PI after 12 h of
 .  .incubation, showed an extensive membrane damage panel A . Zellweger paraformaldehyde-fixed cells incubated as described above ,
 .  .stained with HO 342 panel B , did not show the pattern of chromatin condensation typical of apoptosis 400= .
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gel electrophoresis was performed at 2 Vrcm for 18
h. The DNA in the gel was visualised under UV light
 .by using ethidium bromide 0.5 mgrml into the gel .
2.11. Bcl-2 and PARP Western blots
Western blots were carried out as suggested by
manufacturer’s instructions. Briefly, 3=106 Zell-
weger fibroblast cells were scraped with 500 ml of
RIPA buffer 1= PBS, 1% NP40, 0.5% sodium
.deoxycholate, 0.1% SDS containing freshly added
protease inhibitors and processed for 12% SDS-PAGE
and nitrocellulose membrane transfer, performed as
w xpreviously described 13 . Primary antibodies, diluted
 .  .1:300 anti Bcl-2 and 1:500 or 1:100 anti-PARP ,
were used according to manufacturer’s instructions.
Secondary antibodies were an anti-mouse IgG HRP-
conjugated and an anti-goat IgG HRP-conjugated.
Detection was performed according to ECL proce-
 .dure Amersham, UK .
3. Results
Comparison of normal diploid to Zellweger fibrob-
lasts shows no morphological alterations except a
markedly reduced number of peroxisomes per cell
 .Fig. 1 . Both types of cells grow to confluence with
 .similar kinetics not shown , but exposure to UV
 .irradiation l)320 nm , which has no effects on
proliferation rate in both cell types Fig. 2, 0 mM
.pyrene , had a dramatic effect on Zellweger fibroblast
 .survival but not on normal one when 0.1 mM P12
was added. Interestingly, raising P12 concentration
till to 0.5 mM the results were not modified. At 2
mM, P12 also normal cells viability was greatly
 .reduced Fig. 2 . As shown in Fig. 3, the cellular
localisation of P12, as assessed by fluorescence mi-
croscopy, is similar to that reported by Hoefler et al.
w x5 , staining almost all cytoplasmic membranes. No
difference between normal and Zellweger fibroblasts
was detectable, thus excluding that the killing effect
of P12 is linked to an altered cellular distribution.
The killing effect of UV-activated P12 is probably
linked to the generation of ROS whose effects are
largely prevented by plasmalogens. We detected a
marked increase in superoxide formation 12 h after
UV treatment, both in normal and in Zellweger cells
 .Fig. 4A . However, after 24 h, superoxide produc-
tion was similar to control values. Hydrogen peroxide
 .H O production was strongly elevated 12 h after2 2
UV treatment and again, it declined after 24 h. The
fact that no difference in ROS levels was detectable,
comparing the two cell types, does not exclude that
 .ROS are involved in cell killing Fig. 4B . As shown
in Fig. 5, when the synthetic plasmalogen PAF 40
.mM was added to P12 and UV-treated Zellweger
cells, a high rescue of fibroblasts was observed even
 .at high P12 doses 2 and 4 mM . Lower PAF doses
 .10–20 mM were effective only when 1 mM P12
 .was used not shown . To establish if apoptosis was
involved in the photo-killing mechanism of Zell-
weger fibroblasts, we addressed ourselves to distin-
guish between necrotic and apoptotic cell death fol-
lowing several criteria. In four different flow cyto-
metric analysis, we failed to detect cell morphology
modifications consistent with apoptotic death not
.shown . Fig. 6, panel A, showing PI penetration in
Fig. 7. Time and dose dependent effect of P12 exposure on
internucleosomal DNA degradation determined by gel elec-
trophoresis, performed as described under Section 2.
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most Zellweger-treated cells, suggests the presence of
w xmembrane damage typical of necrotic cell death 14 .
Fig. 6, panel B, representing the HO 342 staining of
Zellweger cells, after P12 and UV treatment, fails to
show the chromatin condensation pattern typical of
apoptosis. Moreover, by using the DNA gel elec-
w xtrophoresis procedure proposed by Gong et al. 12 ,
we did not observe DNA fragmentation in all the
 .conditions tested Fig. 7 .
Several of the biochemical events that contribute
to apoptotic cell death have recently been elucidated.
Bcl-2 is known to protect cells from undergoing
apoptosis in response to a variety of stimuli and it
seems to work preventing the pro-apoptotic effects of
 . w xcysteine proteases caspases activation 15 . In P12-
treated Zellweger fibroblasts, we observed no modifi-
cation of Bcl-2 expression with respect to untreated
 .and to normal cells Fig. 8, panel A and no proteolit-
ical cleavage of PARP, one of the potential substrates
of cysteine proteases during apoptosis Fig. 8, panel
.B . In the second set of experiments, by using con-
 .  .Fig. 8. Detection of Bcl-2 A and PARP B by Western blots.
In each lane, 50 mg of proteins were loaded. U937 cells incu-
bated for 2 h in the presence of ceramide 4 mM, as described by
w x  .Jarvis et al. 16 , served as control of apoptosis panel B . Panel
A, lane 1: U937 untreated cells; lane 2: Zellweger untreated
 .fibroblasts; lane 3: Zellweger-treated fibroblasts 0.5 mM P12 1
h after irradiation; lane 4: Zellweger-treated fibroblasts 0.5 mM
.P12 3 h after irradiation; lane 5: Zellweger-treated fibroblasts
 .0.5 mM P12 6 h after irradiation. Panel B, lane 1: U937-treated
with ceramide; lane 2: Zellweger untreated fibroblasts; lane 3:
 .Zellweger-treated fibroblasts 0.5 mM P12 1 h after irradiation;
 .lane 4: Zellweger-treated fibroblasts 0.5 mM P12 3 h after
 .irradiation; lane 5: Zellweger-treated fibroblasts 0.5 mM P12 6
h after irradiation.
 .centrated 1:100 dilution anti-PARP antibody, we
detected by Western blot unspliced PARP in control
and Zellweger fibroblasts, but not in apoptosis-primed
 .U937 cells not shown .
4. Discussion
Zellweger fibroblasts divide normally and do not
show any sign of damage when cultured for several
days, in fact they are indistinguishable from normal
human diploid fibroblasts using several morphologi-
cal criteria. However, they do not resist, even to mild
photodynamic stress, when a compound such as P12
w xis inserted into membrane phospholipids 4 . As firstly
w xshown by Arias et al. 17 , Zellweger fibroblasts are
characterised by a markedly reduced number of per-
oxisomes. One of the main consequence is the re-
duced activity of dihydroxyacetone phosphate acyl-
 .transferase DHAT and alkyl dihydroxyacetone
 .phosphate synthase ADS , enzymes required for
w xplasmalogen synthesis 17–20 . Although the precise
role of plasmalogens in cell physiology is controver-
w xsial, their capacity to trap ROS is undisputed 8 .
Thus, Zellweger fibroblasts offer the unique opportu-
nity to study the consequences of excessive radical
production on cell constituents.
The well-known capacity of P12 to mediate energy
transfer to oxygen giving rise to ROS, coupled with
the fact that Zellweger fibroblasts but not normal
.ones are damaged by mild photodynamic stresses,
point to the crucial role of plasmalogens in the
protection against radicals. In fact, by using PAF, the
 .killing effect of low doses of P12 less than 2 mM ,
on Zellweger fibroblasts, was almost completely re-
versed.
In order to have reproducible results, care has to
be taken to use doses of P12 lower than 1 mM. At
 .higher doses )2 mM , P12 also inhibits normal
fibroblasts growth and the effect was not reversed
even using 40 mM PAF.
It is widely accepted that ROS can trigger a pro-
 .grammed cell death apoptosis in several kind of
cells, by a mechanism probably involving also the
w xactivation of transcription factors 15 . An alternative
hypothesis to explain the sensitivity of Zellweger
fibroblasts to ROS is to consider the protective role
 .played by Cu, Zn superoxide dismutase SOD . This
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enzyme is normally a peroxisomal enzyme, but in
w xZellweger cells it is mislocated 21 and, as other
mislocated enzymes, its stability is reduced. We can-
not formally exclude that SOD may play a role in the
protection against ROS in fibroblasts, however, the
fact that PAF counteracts the toxic effects of P12,
strongly points to the importance of plasmalogens.
The absence of differences in H O and superox-2 2
ide production, when comparing normal to Zellweger
fibroblasts, indicate that the lack of peroxisomes does
not impair catalase and SOD activities. It is likely
w xthat the two mislocated peroxisomal enzymes 22
retain much of their activity. However, mislocation of
enzymes participating to plasmalogen biosynthesis
w xstrongly reduces their stability 20 .
Cells undergoing apoptotic death frequently reveal
a characteristic sequence of cytological alterations
including membrane blebbing, nuclear and cytoplas-
mic condensation and finally DNA fragmentation
w x23 . It is now clear that these events, considered the
early signals of apoptotic cell death, are preceded by
modification of cytoplasmic organelles function, gen-
erally resulting in massive production of ROS re-
w x.viewed in Ref. 23 . In the last few years, the most
 .studied ROS are the hydrogen peroxide H O , oxy-2 2
 y.gen superoxide O and singlet oxygen. The impor-2
tance of these agents in triggering apoptosis has been
underlined by the discovery regarding the protoonco-
gene Bcl-2, which protects cells from oxidative stress
w xby activating the cellular antioxidant defenses 24 .
w xThe reports of Hoefler et al. 5 on the mechanism of
action of P12 killing as well as our observation that
PAF protects Zellweger fibroblasts are clear indica-
tions of the importance of plasmalogens in protecting
cells from oxidant stress.
Incorporation of P12 into Zellweger fibroblast
membranes may be the basis of an efficient selection
procedure aimed at identifying genes capable of
restoring plasmalogen biosynthesis. Gene transfer ex-
periments using fibroblasts from adrenoleukodys-
trophic patients resulted in a complete correction of
impaired b-oxidation of very long chain fatty acids
w x25 . A similar procedure could be used on Zellweger
fibroblasts, although difficulties could be due to the
severity of the disease which involves a near com-
plete absence of peroxisomes. The guidelines of this
kind of approach have been laid down during these
last few years. Thus, peroxisomal assembly factors
 .as PAF-1 rather than enzyme genes could be used
w xfor a successful gene transfer approach 26 . As
w xdescribed by De Sario et al. 27 , the use of yeast
artificial chromosomes may open the way to the
discovery of new genes involved in peroxisome bio-
genesis. Our results clearly indicate that in Zellweger
fibroblasts, cell rescue depends on the availability of
plasmalogens and that plasmalogen biosynthesis is
the sole antioxidant mechanism impaired in Zell-
weger cells. In fact, as reported in Fig. 8, Bcl-2 levels
and caspase activity did not show any modification
when P12-treated Zellweger fibroblasts were com-
pared to controls. Bcl-2 expression and caspase activ-
ity cannot be used as markers to differentiate between
w xnecrosis and apoptosis 28,29 . However, while initial
biochemical events leading to necrotic and apoptotic
cell death may be similar since the machinery for
programmed cell death is constitutively expressed
w x30 , late events must be different since apoptosis by
definition involves a reprogramming of gene expres-
sion, while necrosis does not. The results reported
here are relevant to the understanding of Zellweger
syndrome and may facilitate gene transfer experi-
ments aimed at identifying genes involved in peroxi-
some biogenesis andror in the stabilisation of plas-
malogen biosynthetic enzymes.
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